Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis ...
An international team of researchers led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback